A recent study reported that ICAM1 bound with integrins to activate the epithelial-to-mesenchymal transition process through TGF-β/SMAD signaling, ultimately enhancing breast cancer cell invasion [65]. The gene discussed is ICAM1; the disease is breast cancer.